Celebrating and showcasing the top examples of partnerships between pharmaceutical companies and patient groups, the Patient Partnership Index 2022 results have today been announced – with seven companies awarded GOLD for their partnership work in patient advocacy, engagement and communications. - News - PharmaTimes
A record number of entries were submitted to this year’s Patient Partnership Index (PPI), a ground-breaking initiative recognising innovative partnerships between patients and pharmaceutical companies. - News - PharmaTimes
A leading initiative that celebrates partnerships between patients and pharmaceutical companies has announced its panel of judges for 2022. - News - PharmaTimes